Terrie Curran - Nov 21, 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Signature
/s/ Larry Miller, Attorney-in-Fact for Terrie Curran
Stock symbol
PHAT
Transactions as of
Nov 21, 2022
Transactions value $
-$14,650
Form type
4
Date filed
11/23/2022, 03:07 PM
Previous filing
Oct 28, 2022
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$14.6K -1.53K -1.79% $9.60 83.7K Nov 21, 2022 Direct F1
holding PHAT Common Stock 2.24K Nov 21, 2022 by 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.59 to $9.90. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.